{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T04:37:57Z","timestamp":1772944677984,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"NIDA","doi-asserted-by":"publisher","award":["5K23DA049953-S2"],"award-info":[{"award-number":["5K23DA049953-S2"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.japh.2025.102481","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T15:08:15Z","timestamp":1752937695000},"page":"102481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pharmacist roles enhancing substance use disorder treatment access, continuation, and education in a problem-solving court"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2074-8775","authenticated-orcid":false,"given":"Ekaterina","family":"Pivovarova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3585-3604","authenticated-orcid":false,"given":"Peter D.","family":"Friedmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Sawicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2240-5768","authenticated-orcid":false,"given":"Jeffrey","family":"Bratberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.japh.2025.102481_bib3","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jcrimjus.2011.11.009","article-title":"Assessing the effectiveness of drug courts on recidivism: a meta-analytic review of traditional and non-traditional drug courts","volume":"40","author":"Mitchell","year":"2012","journal-title":"J Crim Justice"},{"issue":"3","key":"10.1016\/j.japh.2025.102481_bib4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/07418825.2010.525222","article-title":"Looking inside the black box of drug courts: a meta-analytic review","volume":"28","author":"Shaffer","year":"2011","journal-title":"Justice Q"},{"issue":"6","key":"10.1016\/j.japh.2025.102481_bib5","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jcrimjus.2013.06.005","article-title":"Do drug courts reduce the use of incarceration?: a meta-analysis","volume":"41","author":"Sevigny","year":"2013","journal-title":"J Crim Justice"},{"issue":"12-13","key":"10.1016\/j.japh.2025.102481_bib6","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1081\/JA-120014426","article-title":"Treatment inside the drug treatment court: the who, what, where, and how of treatment services","volume":"37","author":"Taxman","year":"2002","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.japh.2025.102481_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2022.108850","article-title":"Drug court utilization of medications for opioid use disorder in high opioid mortality communities","volume":"141","author":"Marlowe","year":"2022","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"10.1016\/j.japh.2025.102481_bib8","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1177\/00220426221109948","article-title":"Medication-assisted treatment in problem-solving courts: a national survey of state and local court coordinators","volume":"53","author":"Farago","year":"2023","journal-title":"J Drug Issues"},{"key":"10.1016\/j.japh.2025.102481_bib9","article-title":"Facilitators and barriers to collaboration between drug courts and community-based medication for opioid use disorder providers","volume":"147","author":"Pivovarova","year":"2023","journal-title":"J Subst Use Addict Treat"},{"issue":"10","key":"10.1016\/j.japh.2025.102481_bib10","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.cptl.2018.07.015","article-title":"How does a drug court experience influence student pharmacists?","volume":"10","author":"Palombi","year":"2018","journal-title":"Curr Pharm Teach Learn"},{"issue":"3","key":"10.1016\/j.japh.2025.102481_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.24926\/iip.v7i3.455","article-title":"The drug court pharmacist: expanding pharmacy practice and addressing substance abuse","volume":"7","author":"Palombi","year":"2016","journal-title":"Innov Pharm"},{"issue":"6","key":"10.1016\/j.japh.2025.102481_bib12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.9740\/mhc.2018.11.317","article-title":"Case reports of interprofessional care for clients enrolled in a mental health court","volume":"8","author":"DeJongh","year":"2018","journal-title":"Ment Health Clin"},{"issue":"5","key":"10.1016\/j.japh.2025.102481_bib20","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/phar.1923","article-title":"ACCP clinical pharmacist competencies","volume":"37","author":"Saseen","year":"2017","journal-title":"Pharmacother"},{"issue":"6","key":"10.1016\/j.japh.2025.102481_bib13","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/00952990.2020.1807559","article-title":"Beliefs about medications for opioid use disorder among Florida criminal problem-solving court & dependency court staff","volume":"46","author":"Andraka-Christou","year":"2020","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"3","key":"10.1016\/j.japh.2025.102481_bib14","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1177\/29767342241297745","article-title":"Medication for opioid use disorders (MOUD) providers' experiences with recovery courts: qualitative study of individual and systemic factors impacting interagency collaboration","volume":"46","author":"Pivovarova","year":"2025","journal-title":"Subst Use Addctn J"},{"issue":"1","key":"10.1016\/j.japh.2025.102481_bib15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40352-022-00188-4","article-title":"Barriers to medications for opioid use disorder in the court system: provider availability, provider \u201ctrustworthiness,\u201d and cost","volume":"10","author":"Ahmed","year":"2022","journal-title":"Health Justice"},{"issue":"3","key":"10.1016\/j.japh.2025.102481_bib16","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.cnur.2008.04.009","article-title":"Vulnerable populations: drug court program clients","volume":"43","author":"Speck","year":"2008","journal-title":"Nurs Clin North Am"},{"key":"10.1016\/j.japh.2025.102481_bib17","series-title":"Research on Drug Courts: A Critical Review 2001 Update","author":"Belenko","year":"2001"},{"key":"10.1016\/j.japh.2025.102481_bib18","series-title":"Drug overdose deaths in the United States, 2003-2023. NCHS Data Brief, no 522","author":"Garnett","year":"2024"},{"key":"10.1016\/j.japh.2025.102481_bib19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jsat.2016.08.017","article-title":"Identifying and addressing the unmet health care needs of drug court clients","volume":"71","author":"Dugosh","year":"2016","journal-title":"J substance abuse Treat"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319125001608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319125001608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T13:37:29Z","timestamp":1772890649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319125001608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1544319125001608"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2025.102481","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacist roles enhancing substance use disorder treatment access, continuation, and education in a problem-solving court","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2025.102481","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102481"}}